Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Pamela Seam, Upendra Mahat, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Yuxia Jia, Shu Wang, Zhiheng Xu, Yvette Kasamon, Bindu Kanaparu, Nicholas Richardson, Nicole Gormley

Blood (2023) 142 (Supplement 1): 6919.

https://doi.org/10.1182/blood-2023-186544

Published: 2023

Journal Articles

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

Upendra Mahat, Pamela Seam, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Shu Wang, Zhiheng Xu, Yuxia Jia, Nicholas Richardson, Bindu Kanapuru, Yvette Kasamon, Nicole Gormley

Blood (2023) 142 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2023-182279

Published: 2023

Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD

Blood (2019) 134 (Supplement_1): 3450.

https://doi.org/10.1182/blood-2019-125798

Published: 2019

Journal Articles

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Poornima Sharma, MD, Harpreet Singh, MD, Najat Bouchkouj, MD, Aviva C. Krauss, MD, Bindu George, MD

Blood (2018) 132 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2018-99-115188

Published: 2018

Journal Articles

Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas.

Najat Bouchkouj, MD, Shannon Larabee, Haying Qin, Joanna Louise Meadors, BS, Crystal L Mackall, MD, Terry J Fry, MD

Blood (2010) 116 (21): 3792.

https://doi.org/10.1182/blood.V116.21.3792.3792

Published: 2010

NARROW

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas.

Email alerts

ASH Publications

American Society of Hematology

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only